GSK2269557
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for GSK2269557, covering 2017-01-18 to 2019-11-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation [Phase 2]